Skip to main navigation Skip to search Skip to main content

Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, “Prediabetes,” Diabetes and Atherosclerosis

  • University of Crete
  • University College London

Research output: Contribution to journal › Review article › peer-review

75 Scopus citations

Abstract

Fat accumulation in the pancreas associated with obesity and the metabolic syndrome (MetS) has been defined as “non-alcoholic fatty pancreas disease” (NAFPD). The aim of this review is to describe the association of NAFPD with obesity, MetS, type 2 diabetes mellitus (T2DM) and atherosclerosis and also increase awareness regarding NAFPD. Various methods are used for the detection and quantification of pancreatic fat accumulation that may play a significant role in the differences that have been observed in the prevalence of NAFPD. Endoscopic ultrasound provides detailed images of the pancreas and its use is expected to increase in the future. Obesity and MetS have been recognized as NAFPD risk factors. NAFPD is strongly associated with non-alcoholic fatty liver disease (NAFLD) and it seems that the presence of both may be related with aggravation of NAFLD. A role of NAFPD in the development of “prediabetes” and T2DM has also been suggested by most human studies. Accumulation of fat in pancreatic tissue possibly initiates a vicious cycle of beta-cell deterioration and further pancreatic fat accumulation. Additionally, some evidence indicates a correlation between NAFPD and atherosclerotic markers (e.g., carotid intima–media thickness). Weight loss and bariatric surgery decreases pancreatic triglyceride content but pharmacologic treatments for NAFPD have not been evaluated in specifically designed studies. Hence, NAFPD is a marker of local fat accumulation possibly associated with beta-cell function impairment, carbohydrate metabolism disorders and atherosclerosis.

Original languageEnglish
Pages (from-to)26-41
Number of pages16
JournalDigestive Diseases and Sciences
Volume67
Issue number1
DOIs
StatePublished - Jan 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Atherosclerosis
  • Metabolic syndrome
  • Non-alcoholic fatty liver disease
  • Non-alcoholic fatty pancreas disease
  • Obesity
  • Type 2 diabetes mellitus

Fingerprint

Dive into the research topics of 'Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, “Prediabetes,” Diabetes and Atherosclerosis'. Together they form a unique fingerprint.

Cite this